Physician profile
David B Bumpass
NPI 1265688733
$174,528.27
in general payments reported to CMS, 2019-2025
11 companies · $32K in 2025
The $32K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $9,277 · 2021: $33K · 2022: $23K · 2023: $980 · 2024: $36K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $6,591 · Food and Beverage: $2,644 · Royalty Or License: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,487.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,750.00 |
| Travel and Lodging | $6,591.08 |
| Food and Beverage | $2,643.94 |
| Royalty Or License | $341.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $111,703.00 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Medtronic USA, INC. | $45,463.08 | 2019-2020 | |
| Orthopediatrics Corp. | $15,640.03 | 2019-2025 | |
| Nuvasive, INC. | $520.86 | 2021-2023 | Magec Spinal Bracing and Distraction System |
| Globus Medical, INC. | $326.05 | 2022-2025 | Modulus |
| Corelink, LLC | $282.33 | 2019 | |
| Alphatec Spine, INC | $215.47 | 2024 | Other - Miscellaneous |
| Acuity Surgical Devices, LLC | $166.93 | 2022-2024 | |
| Medacta USA, INC. | $154.25 | 2024 | |
| Midsouth Orthopedics INC. | $56.27 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$99,996.85 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bumpass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.